drugset / Trial / NCT00942864
Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of intravitreal Lucentis® (Ranibizumab) and investigate the anatomical and functional improvement following this treatment in patients with macular edema due to retinal vein occlusion (RVO).
Timeline
- Start
- 2008-12
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |